At the end of the latest market close, Intercept Pharmaceuticals Inc. (ICPT) was valued at $12.25. In that particular session, Stock kicked-off at the price of $12.62 while reaching the peak value of $14.1288 and lowest value recorded on the day was $12.51. The stock current value is $13.84.Recently in News on August 3, 2022, Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update. Worldwide Ocaliva® non-GAAP adjusted net sales in PBC of $100.4 million; U.S. net sales of $71.8 million representing 5% growth over the prior year quarter. You can read further details here
Intercept Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $20.00 on 05/05/22, with the lowest value was $10.81 for the same time period, recorded on 06/16/22.
Intercept Pharmaceuticals Inc. (ICPT) full year performance was -16.83%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intercept Pharmaceuticals Inc. shares are logging -32.49% during the 52-week period from high price, and 28.03% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $10.81 and $20.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1763546 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Intercept Pharmaceuticals Inc. (ICPT) recorded performance in the market was -15.04%, having the revenues showcasing -12.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 467.24M, as it employees total of 437 workers.
Market experts do have their say about Intercept Pharmaceuticals Inc. (ICPT)
During the last month, 0 analysts gave the Intercept Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 15.63, with a change in the price was noted -1.40. In a similar fashion, Intercept Pharmaceuticals Inc. posted a movement of -9.19% for the period of last 100 days, recording 935,920 in trading volumes.
Technical breakdown of Intercept Pharmaceuticals Inc. (ICPT)
Raw Stochastic average of Intercept Pharmaceuticals Inc. in the period of last 50 days is set at 37.78%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 48.07%. In the last 20 days, the company’s Stochastic %K was 18.87% and its Stochastic %D was recorded 11.60%.
Bearing in mind the latest performance of Intercept Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.04%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -18.15%, alongside a downfall of -16.83% for the period of the last 12 months. The shares increased approximately by -4.55% in the 7-day charts and went up by -8.65% in the period of the last 30 days. Common stock shares were lifted by -12.46% during last recorded quarter.